nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AI in medicine: creating a safe and equitable future
|
The Lancet, |
|
|
402 |
10401 |
p. 503 |
artikel |
2 |
A need for safe infant feeding in low-resource health-care facilities
|
Nadimpalli, Maya L |
|
|
402 |
10401 |
p. 525-526 |
artikel |
3 |
A new class of glucose-lowering therapy for type 2 diabetes: the latest development in the incretin arena
|
Bain, Stephen C |
|
|
402 |
10401 |
p. 504-505 |
artikel |
4 |
Are we training our students to be white saviours in global health?
|
Banerjee, Ananya Tina |
|
|
402 |
10401 |
p. 520-521 |
artikel |
5 |
Author gender representation of journal reviews and editorials on lymphoma (2017–22)
|
Hawkes, Eliza A |
|
|
402 |
10401 |
p. 523-525 |
artikel |
6 |
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
|
Ramanan, Athimalaipet V |
|
|
402 |
10401 |
p. 555-570 |
artikel |
7 |
Department of Error
|
|
|
|
402 |
10401 |
p. 528 |
artikel |
8 |
Department of Error
|
|
|
|
402 |
10401 |
p. 528 |
artikel |
9 |
Evelyn Ruth Maisel Witkin
|
Watts, Geoff |
|
|
402 |
10401 |
p. 522 |
artikel |
10 |
Janus kinase inhibition in juvenile idiopathic arthritis
|
Rife, Eileen C |
|
|
402 |
10401 |
p. 508-509 |
artikel |
11 |
Misclassification of overdose events in the X:BOT study
|
Dasgupta, Nabarun |
|
|
402 |
10401 |
p. 526-527 |
artikel |
12 |
Misclassification of overdose events in the X:BOT study – Authors' reply
|
Lee, Joshua D |
|
|
402 |
10401 |
p. 527-528 |
artikel |
13 |
mRNA vaccines do not stop with COVID-19
|
Zhou, Jin |
|
|
402 |
10401 |
p. 526 |
artikel |
14 |
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
|
Rosenstock, Julio |
|
|
402 |
10401 |
p. 529-544 |
artikel |
15 |
Rising tide: opportunities for accelerating action on drowning prevention
|
Jagnoor, Jagnoor |
|
|
402 |
10401 |
p. 512-514 |
artikel |
16 |
Syphilis rates soar in the USA amid penicillin shortage
|
Nelson, Roxanne |
|
|
402 |
10401 |
p. 515 |
artikel |
17 |
Tech companies criticise health AI regulations
|
Webster, Paul |
|
|
402 |
10401 |
p. 517-518 |
artikel |
18 |
The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery
|
O'Brien, Katherine L |
|
|
402 |
10401 |
p. 510-512 |
artikel |
19 |
Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial
|
Burkhardt, Gerrit |
|
|
402 |
10401 |
p. 545-554 |
artikel |
20 |
Transcranial direct current stimulation as a treatment for major depressive disorder
|
Voineskos, Daphne |
|
|
402 |
10401 |
p. 506-507 |
artikel |
21 |
UK aid cuts will lead to thousands of deaths
|
Devi, Sharmila |
|
|
402 |
10401 |
p. 516 |
artikel |
22 |
Ulcerative colitis
|
Le Berre, Catherine |
|
|
402 |
10401 |
p. 571-584 |
artikel |
23 |
Vanessa Kerry: driving action on climate change and health
|
Samarasekera, Udani |
|
|
402 |
10401 |
p. 519 |
artikel |
24 |
Venous insufficiency and acrocyanosis in long COVID: dysautonomia
|
Iftekhar, Nafi |
|
|
402 |
10401 |
p. e9 |
artikel |